Global Formulation CDMO Services Supply, Demand and Key Producers, 2023-2029
The global Formulation CDMO Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Formulation CDMO services usually include the following services: formulation development, technology transfer, preparation of prescriptions, process standards, mass production, quality control and analysis, and registration support. Through the preparation CDMO service, the development and manufacture of preparations can be entrusted to professional institutions, thereby reducing their own R&D and production costs, and can speed up the process of launching products with the help of the experience and facilities of CDMO institutions. At the same time, the preparation CDMO service can also help customers ensure the quality, safety and regulatory compliance of preparation products, and improve the market competitiveness of products.
Formulation CDMO services refer to a contract development and manufacturing organization that provides pharmaceutical formulation development and manufacturing services. It provides pharmaceutical companies and biotechnology companies with a full range of formulation solutions from the drug development stage to the commercial production stage.
This report studies the global Formulation CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Formulation CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Formulation CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Formulation CDMO Services total market, 2018-2029, (USD Million)
Global Formulation CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Formulation CDMO Services total market, key domestic companies and share, (USD Million)
Global Formulation CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Formulation CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Formulation CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Formulation CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medicilon, Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, Pfizer, Polypeptide and Bachem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Formulation CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Formulation CDMO Services Market, By Region:
1. How big is the global Formulation CDMO Services market?
2. What is the demand of the global Formulation CDMO Services market?
3. What is the year over year growth of the global Formulation CDMO Services market?
4. What is the total value of the global Formulation CDMO Services market?
5. Who are the major players in the global Formulation CDMO Services market?
6. What are the growth factors driving the market demand?
Formulation CDMO services usually include the following services: formulation development, technology transfer, preparation of prescriptions, process standards, mass production, quality control and analysis, and registration support. Through the preparation CDMO service, the development and manufacture of preparations can be entrusted to professional institutions, thereby reducing their own R&D and production costs, and can speed up the process of launching products with the help of the experience and facilities of CDMO institutions. At the same time, the preparation CDMO service can also help customers ensure the quality, safety and regulatory compliance of preparation products, and improve the market competitiveness of products.
Formulation CDMO services refer to a contract development and manufacturing organization that provides pharmaceutical formulation development and manufacturing services. It provides pharmaceutical companies and biotechnology companies with a full range of formulation solutions from the drug development stage to the commercial production stage.
This report studies the global Formulation CDMO Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Formulation CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Formulation CDMO Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Formulation CDMO Services total market, 2018-2029, (USD Million)
Global Formulation CDMO Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Formulation CDMO Services total market, key domestic companies and share, (USD Million)
Global Formulation CDMO Services revenue by player and market share 2018-2023, (USD Million)
Global Formulation CDMO Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Formulation CDMO Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Formulation CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medicilon, Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, Pfizer, Polypeptide and Bachem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Formulation CDMO Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Formulation CDMO Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Small Molecule CDMO
- Macro-molecular CDMO
- Clinical Application
- Commercial Production
- Medicilon
- Gliead
- Boehringer Ingelheim
- Vertex
- Mirati Therapeutics
- AMPAC
- Pfizer
- Polypeptide
- Bachem
- Merck
- Asymchem
- Zhejiang Jiuzhou Pharmaceutical
- Sinopep
- Frontier Biotechnologies
- JYMed
- Chengdu Shengnuo Biotechnology
- Shanghai Soho-Yiming Pharmaceuticals
- Chinese Peptide Company
- Ambio Pharmaceuticals
- Zhejiang Peptites Biotech
- STA Pharmaceutical
- Zhejiang Langhua Pharmaceutical
- Viva Biotech
1. How big is the global Formulation CDMO Services market?
2. What is the demand of the global Formulation CDMO Services market?
3. What is the year over year growth of the global Formulation CDMO Services market?
4. What is the total value of the global Formulation CDMO Services market?
5. Who are the major players in the global Formulation CDMO Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Formulation CDMO Services Introduction
1.2 World Formulation CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Formulation CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Formulation CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Formulation CDMO Services Market Size (2018-2029)
1.3.3 China Formulation CDMO Services Market Size (2018-2029)
1.3.4 Europe Formulation CDMO Services Market Size (2018-2029)
1.3.5 Japan Formulation CDMO Services Market Size (2018-2029)
1.3.6 South Korea Formulation CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Formulation CDMO Services Market Size (2018-2029)
1.3.8 India Formulation CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Formulation CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Formulation CDMO Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Formulation CDMO Services Consumption Value (2018-2029)
2.2 World Formulation CDMO Services Consumption Value by Region
2.2.1 World Formulation CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Formulation CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Formulation CDMO Services Consumption Value (2018-2029)
2.4 China Formulation CDMO Services Consumption Value (2018-2029)
2.5 Europe Formulation CDMO Services Consumption Value (2018-2029)
2.6 Japan Formulation CDMO Services Consumption Value (2018-2029)
2.7 South Korea Formulation CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Formulation CDMO Services Consumption Value (2018-2029)
2.9 India Formulation CDMO Services Consumption Value (2018-2029)
3 WORLD FORMULATION CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Formulation CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Formulation CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Formulation CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Formulation CDMO Services in 2022
3.3 Formulation CDMO Services Company Evaluation Quadrant
3.4 Formulation CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Formulation CDMO Services Market: Region Footprint
3.4.2 Formulation CDMO Services Market: Company Product Type Footprint
3.4.3 Formulation CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Formulation CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Formulation CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Formulation CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Formulation CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Formulation CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Formulation CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Formulation CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Formulation CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Formulation CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Formulation CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Formulation CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Formulation CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Formulation CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Formulation CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Formulation CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Formulation CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Small Molecule CDMO
5.2.2 Macro-molecular CDMO
5.3 Market Segment by Type
5.3.1 World Formulation CDMO Services Market Size by Type (2018-2023)
5.3.2 World Formulation CDMO Services Market Size by Type (2024-2029)
5.3.3 World Formulation CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Formulation CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Application
6.2.2 Commercial Production
6.3 Market Segment by Application
6.3.1 World Formulation CDMO Services Market Size by Application (2018-2023)
6.3.2 World Formulation CDMO Services Market Size by Application (2024-2029)
6.3.3 World Formulation CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medicilon
7.1.1 Medicilon Details
7.1.2 Medicilon Major Business
7.1.3 Medicilon Formulation CDMO Services Product and Services
7.1.4 Medicilon Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medicilon Recent Developments/Updates
7.1.6 Medicilon Competitive Strengths & Weaknesses
7.2 Gliead
7.2.1 Gliead Details
7.2.2 Gliead Major Business
7.2.3 Gliead Formulation CDMO Services Product and Services
7.2.4 Gliead Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gliead Recent Developments/Updates
7.2.6 Gliead Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Details
7.3.2 Boehringer Ingelheim Major Business
7.3.3 Boehringer Ingelheim Formulation CDMO Services Product and Services
7.3.4 Boehringer Ingelheim Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Ingelheim Recent Developments/Updates
7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Vertex
7.4.1 Vertex Details
7.4.2 Vertex Major Business
7.4.3 Vertex Formulation CDMO Services Product and Services
7.4.4 Vertex Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Vertex Recent Developments/Updates
7.4.6 Vertex Competitive Strengths & Weaknesses
7.5 Mirati Therapeutics
7.5.1 Mirati Therapeutics Details
7.5.2 Mirati Therapeutics Major Business
7.5.3 Mirati Therapeutics Formulation CDMO Services Product and Services
7.5.4 Mirati Therapeutics Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Mirati Therapeutics Recent Developments/Updates
7.5.6 Mirati Therapeutics Competitive Strengths & Weaknesses
7.6 AMPAC
7.6.1 AMPAC Details
7.6.2 AMPAC Major Business
7.6.3 AMPAC Formulation CDMO Services Product and Services
7.6.4 AMPAC Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 AMPAC Recent Developments/Updates
7.6.6 AMPAC Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer Formulation CDMO Services Product and Services
7.7.4 Pfizer Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Polypeptide
7.8.1 Polypeptide Details
7.8.2 Polypeptide Major Business
7.8.3 Polypeptide Formulation CDMO Services Product and Services
7.8.4 Polypeptide Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Polypeptide Recent Developments/Updates
7.8.6 Polypeptide Competitive Strengths & Weaknesses
7.9 Bachem
7.9.1 Bachem Details
7.9.2 Bachem Major Business
7.9.3 Bachem Formulation CDMO Services Product and Services
7.9.4 Bachem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bachem Recent Developments/Updates
7.9.6 Bachem Competitive Strengths & Weaknesses
7.10 Merck
7.10.1 Merck Details
7.10.2 Merck Major Business
7.10.3 Merck Formulation CDMO Services Product and Services
7.10.4 Merck Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Merck Recent Developments/Updates
7.10.6 Merck Competitive Strengths & Weaknesses
7.11 Asymchem
7.11.1 Asymchem Details
7.11.2 Asymchem Major Business
7.11.3 Asymchem Formulation CDMO Services Product and Services
7.11.4 Asymchem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Asymchem Recent Developments/Updates
7.11.6 Asymchem Competitive Strengths & Weaknesses
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Details
7.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
7.12.3 Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Product and Services
7.12.4 Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
7.12.6 Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
7.13 Sinopep
7.13.1 Sinopep Details
7.13.2 Sinopep Major Business
7.13.3 Sinopep Formulation CDMO Services Product and Services
7.13.4 Sinopep Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sinopep Recent Developments/Updates
7.13.6 Sinopep Competitive Strengths & Weaknesses
7.14 Frontier Biotechnologies
7.14.1 Frontier Biotechnologies Details
7.14.2 Frontier Biotechnologies Major Business
7.14.3 Frontier Biotechnologies Formulation CDMO Services Product and Services
7.14.4 Frontier Biotechnologies Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Frontier Biotechnologies Recent Developments/Updates
7.14.6 Frontier Biotechnologies Competitive Strengths & Weaknesses
7.15 JYMed
7.15.1 JYMed Details
7.15.2 JYMed Major Business
7.15.3 JYMed Formulation CDMO Services Product and Services
7.15.4 JYMed Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 JYMed Recent Developments/Updates
7.15.6 JYMed Competitive Strengths & Weaknesses
7.16 Chengdu Shengnuo Biotechnology
7.16.1 Chengdu Shengnuo Biotechnology Details
7.16.2 Chengdu Shengnuo Biotechnology Major Business
7.16.3 Chengdu Shengnuo Biotechnology Formulation CDMO Services Product and Services
7.16.4 Chengdu Shengnuo Biotechnology Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Chengdu Shengnuo Biotechnology Recent Developments/Updates
7.16.6 Chengdu Shengnuo Biotechnology Competitive Strengths & Weaknesses
7.17 Shanghai Soho-Yiming Pharmaceuticals
7.17.1 Shanghai Soho-Yiming Pharmaceuticals Details
7.17.2 Shanghai Soho-Yiming Pharmaceuticals Major Business
7.17.3 Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Product and Services
7.17.4 Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
7.17.6 Shanghai Soho-Yiming Pharmaceuticals Competitive Strengths & Weaknesses
7.18 Chinese Peptide Company
7.18.1 Chinese Peptide Company Details
7.18.2 Chinese Peptide Company Major Business
7.18.3 Chinese Peptide Company Formulation CDMO Services Product and Services
7.18.4 Chinese Peptide Company Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Chinese Peptide Company Recent Developments/Updates
7.18.6 Chinese Peptide Company Competitive Strengths & Weaknesses
7.19 Ambio Pharmaceuticals
7.19.1 Ambio Pharmaceuticals Details
7.19.2 Ambio Pharmaceuticals Major Business
7.19.3 Ambio Pharmaceuticals Formulation CDMO Services Product and Services
7.19.4 Ambio Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Ambio Pharmaceuticals Recent Developments/Updates
7.19.6 Ambio Pharmaceuticals Competitive Strengths & Weaknesses
7.20 Zhejiang Peptites Biotech
7.20.1 Zhejiang Peptites Biotech Details
7.20.2 Zhejiang Peptites Biotech Major Business
7.20.3 Zhejiang Peptites Biotech Formulation CDMO Services Product and Services
7.20.4 Zhejiang Peptites Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Zhejiang Peptites Biotech Recent Developments/Updates
7.20.6 Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
7.21 STA Pharmaceutical
7.21.1 STA Pharmaceutical Details
7.21.2 STA Pharmaceutical Major Business
7.21.3 STA Pharmaceutical Formulation CDMO Services Product and Services
7.21.4 STA Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 STA Pharmaceutical Recent Developments/Updates
7.21.6 STA Pharmaceutical Competitive Strengths & Weaknesses
7.22 Zhejiang Langhua Pharmaceutical
7.22.1 Zhejiang Langhua Pharmaceutical Details
7.22.2 Zhejiang Langhua Pharmaceutical Major Business
7.22.3 Zhejiang Langhua Pharmaceutical Formulation CDMO Services Product and Services
7.22.4 Zhejiang Langhua Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Zhejiang Langhua Pharmaceutical Recent Developments/Updates
7.22.6 Zhejiang Langhua Pharmaceutical Competitive Strengths & Weaknesses
7.23 Viva Biotech
7.23.1 Viva Biotech Details
7.23.2 Viva Biotech Major Business
7.23.3 Viva Biotech Formulation CDMO Services Product and Services
7.23.4 Viva Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Viva Biotech Recent Developments/Updates
7.23.6 Viva Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Formulation CDMO Services Industry Chain
8.2 Formulation CDMO Services Upstream Analysis
8.3 Formulation CDMO Services Midstream Analysis
8.4 Formulation CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Formulation CDMO Services Introduction
1.2 World Formulation CDMO Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Formulation CDMO Services Total Market by Region (by Headquarter Location)
1.3.1 World Formulation CDMO Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Formulation CDMO Services Market Size (2018-2029)
1.3.3 China Formulation CDMO Services Market Size (2018-2029)
1.3.4 Europe Formulation CDMO Services Market Size (2018-2029)
1.3.5 Japan Formulation CDMO Services Market Size (2018-2029)
1.3.6 South Korea Formulation CDMO Services Market Size (2018-2029)
1.3.7 ASEAN Formulation CDMO Services Market Size (2018-2029)
1.3.8 India Formulation CDMO Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Formulation CDMO Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Formulation CDMO Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Formulation CDMO Services Consumption Value (2018-2029)
2.2 World Formulation CDMO Services Consumption Value by Region
2.2.1 World Formulation CDMO Services Consumption Value by Region (2018-2023)
2.2.2 World Formulation CDMO Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Formulation CDMO Services Consumption Value (2018-2029)
2.4 China Formulation CDMO Services Consumption Value (2018-2029)
2.5 Europe Formulation CDMO Services Consumption Value (2018-2029)
2.6 Japan Formulation CDMO Services Consumption Value (2018-2029)
2.7 South Korea Formulation CDMO Services Consumption Value (2018-2029)
2.8 ASEAN Formulation CDMO Services Consumption Value (2018-2029)
2.9 India Formulation CDMO Services Consumption Value (2018-2029)
3 WORLD FORMULATION CDMO SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Formulation CDMO Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Formulation CDMO Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Formulation CDMO Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Formulation CDMO Services in 2022
3.3 Formulation CDMO Services Company Evaluation Quadrant
3.4 Formulation CDMO Services Market: Overall Company Footprint Analysis
3.4.1 Formulation CDMO Services Market: Region Footprint
3.4.2 Formulation CDMO Services Market: Company Product Type Footprint
3.4.3 Formulation CDMO Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Formulation CDMO Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Formulation CDMO Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Formulation CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Formulation CDMO Services Consumption Value Comparison
4.2.1 United States VS China: Formulation CDMO Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Formulation CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Formulation CDMO Services Companies and Market Share, 2018-2023
4.3.1 United States Based Formulation CDMO Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Formulation CDMO Services Revenue, (2018-2023)
4.4 China Based Companies Formulation CDMO Services Revenue and Market Share, 2018-2023
4.4.1 China Based Formulation CDMO Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Formulation CDMO Services Revenue, (2018-2023)
4.5 Rest of World Based Formulation CDMO Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Formulation CDMO Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Formulation CDMO Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Formulation CDMO Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Small Molecule CDMO
5.2.2 Macro-molecular CDMO
5.3 Market Segment by Type
5.3.1 World Formulation CDMO Services Market Size by Type (2018-2023)
5.3.2 World Formulation CDMO Services Market Size by Type (2024-2029)
5.3.3 World Formulation CDMO Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Formulation CDMO Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Application
6.2.2 Commercial Production
6.3 Market Segment by Application
6.3.1 World Formulation CDMO Services Market Size by Application (2018-2023)
6.3.2 World Formulation CDMO Services Market Size by Application (2024-2029)
6.3.3 World Formulation CDMO Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medicilon
7.1.1 Medicilon Details
7.1.2 Medicilon Major Business
7.1.3 Medicilon Formulation CDMO Services Product and Services
7.1.4 Medicilon Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medicilon Recent Developments/Updates
7.1.6 Medicilon Competitive Strengths & Weaknesses
7.2 Gliead
7.2.1 Gliead Details
7.2.2 Gliead Major Business
7.2.3 Gliead Formulation CDMO Services Product and Services
7.2.4 Gliead Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gliead Recent Developments/Updates
7.2.6 Gliead Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Details
7.3.2 Boehringer Ingelheim Major Business
7.3.3 Boehringer Ingelheim Formulation CDMO Services Product and Services
7.3.4 Boehringer Ingelheim Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Ingelheim Recent Developments/Updates
7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Vertex
7.4.1 Vertex Details
7.4.2 Vertex Major Business
7.4.3 Vertex Formulation CDMO Services Product and Services
7.4.4 Vertex Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Vertex Recent Developments/Updates
7.4.6 Vertex Competitive Strengths & Weaknesses
7.5 Mirati Therapeutics
7.5.1 Mirati Therapeutics Details
7.5.2 Mirati Therapeutics Major Business
7.5.3 Mirati Therapeutics Formulation CDMO Services Product and Services
7.5.4 Mirati Therapeutics Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Mirati Therapeutics Recent Developments/Updates
7.5.6 Mirati Therapeutics Competitive Strengths & Weaknesses
7.6 AMPAC
7.6.1 AMPAC Details
7.6.2 AMPAC Major Business
7.6.3 AMPAC Formulation CDMO Services Product and Services
7.6.4 AMPAC Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 AMPAC Recent Developments/Updates
7.6.6 AMPAC Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer Formulation CDMO Services Product and Services
7.7.4 Pfizer Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Polypeptide
7.8.1 Polypeptide Details
7.8.2 Polypeptide Major Business
7.8.3 Polypeptide Formulation CDMO Services Product and Services
7.8.4 Polypeptide Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Polypeptide Recent Developments/Updates
7.8.6 Polypeptide Competitive Strengths & Weaknesses
7.9 Bachem
7.9.1 Bachem Details
7.9.2 Bachem Major Business
7.9.3 Bachem Formulation CDMO Services Product and Services
7.9.4 Bachem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bachem Recent Developments/Updates
7.9.6 Bachem Competitive Strengths & Weaknesses
7.10 Merck
7.10.1 Merck Details
7.10.2 Merck Major Business
7.10.3 Merck Formulation CDMO Services Product and Services
7.10.4 Merck Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Merck Recent Developments/Updates
7.10.6 Merck Competitive Strengths & Weaknesses
7.11 Asymchem
7.11.1 Asymchem Details
7.11.2 Asymchem Major Business
7.11.3 Asymchem Formulation CDMO Services Product and Services
7.11.4 Asymchem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Asymchem Recent Developments/Updates
7.11.6 Asymchem Competitive Strengths & Weaknesses
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Details
7.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
7.12.3 Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Product and Services
7.12.4 Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
7.12.6 Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
7.13 Sinopep
7.13.1 Sinopep Details
7.13.2 Sinopep Major Business
7.13.3 Sinopep Formulation CDMO Services Product and Services
7.13.4 Sinopep Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sinopep Recent Developments/Updates
7.13.6 Sinopep Competitive Strengths & Weaknesses
7.14 Frontier Biotechnologies
7.14.1 Frontier Biotechnologies Details
7.14.2 Frontier Biotechnologies Major Business
7.14.3 Frontier Biotechnologies Formulation CDMO Services Product and Services
7.14.4 Frontier Biotechnologies Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Frontier Biotechnologies Recent Developments/Updates
7.14.6 Frontier Biotechnologies Competitive Strengths & Weaknesses
7.15 JYMed
7.15.1 JYMed Details
7.15.2 JYMed Major Business
7.15.3 JYMed Formulation CDMO Services Product and Services
7.15.4 JYMed Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 JYMed Recent Developments/Updates
7.15.6 JYMed Competitive Strengths & Weaknesses
7.16 Chengdu Shengnuo Biotechnology
7.16.1 Chengdu Shengnuo Biotechnology Details
7.16.2 Chengdu Shengnuo Biotechnology Major Business
7.16.3 Chengdu Shengnuo Biotechnology Formulation CDMO Services Product and Services
7.16.4 Chengdu Shengnuo Biotechnology Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Chengdu Shengnuo Biotechnology Recent Developments/Updates
7.16.6 Chengdu Shengnuo Biotechnology Competitive Strengths & Weaknesses
7.17 Shanghai Soho-Yiming Pharmaceuticals
7.17.1 Shanghai Soho-Yiming Pharmaceuticals Details
7.17.2 Shanghai Soho-Yiming Pharmaceuticals Major Business
7.17.3 Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Product and Services
7.17.4 Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
7.17.6 Shanghai Soho-Yiming Pharmaceuticals Competitive Strengths & Weaknesses
7.18 Chinese Peptide Company
7.18.1 Chinese Peptide Company Details
7.18.2 Chinese Peptide Company Major Business
7.18.3 Chinese Peptide Company Formulation CDMO Services Product and Services
7.18.4 Chinese Peptide Company Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Chinese Peptide Company Recent Developments/Updates
7.18.6 Chinese Peptide Company Competitive Strengths & Weaknesses
7.19 Ambio Pharmaceuticals
7.19.1 Ambio Pharmaceuticals Details
7.19.2 Ambio Pharmaceuticals Major Business
7.19.3 Ambio Pharmaceuticals Formulation CDMO Services Product and Services
7.19.4 Ambio Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Ambio Pharmaceuticals Recent Developments/Updates
7.19.6 Ambio Pharmaceuticals Competitive Strengths & Weaknesses
7.20 Zhejiang Peptites Biotech
7.20.1 Zhejiang Peptites Biotech Details
7.20.2 Zhejiang Peptites Biotech Major Business
7.20.3 Zhejiang Peptites Biotech Formulation CDMO Services Product and Services
7.20.4 Zhejiang Peptites Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Zhejiang Peptites Biotech Recent Developments/Updates
7.20.6 Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
7.21 STA Pharmaceutical
7.21.1 STA Pharmaceutical Details
7.21.2 STA Pharmaceutical Major Business
7.21.3 STA Pharmaceutical Formulation CDMO Services Product and Services
7.21.4 STA Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 STA Pharmaceutical Recent Developments/Updates
7.21.6 STA Pharmaceutical Competitive Strengths & Weaknesses
7.22 Zhejiang Langhua Pharmaceutical
7.22.1 Zhejiang Langhua Pharmaceutical Details
7.22.2 Zhejiang Langhua Pharmaceutical Major Business
7.22.3 Zhejiang Langhua Pharmaceutical Formulation CDMO Services Product and Services
7.22.4 Zhejiang Langhua Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Zhejiang Langhua Pharmaceutical Recent Developments/Updates
7.22.6 Zhejiang Langhua Pharmaceutical Competitive Strengths & Weaknesses
7.23 Viva Biotech
7.23.1 Viva Biotech Details
7.23.2 Viva Biotech Major Business
7.23.3 Viva Biotech Formulation CDMO Services Product and Services
7.23.4 Viva Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Viva Biotech Recent Developments/Updates
7.23.6 Viva Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Formulation CDMO Services Industry Chain
8.2 Formulation CDMO Services Upstream Analysis
8.3 Formulation CDMO Services Midstream Analysis
8.4 Formulation CDMO Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Formulation CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Formulation CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Formulation CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Formulation CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Formulation CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Formulation CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Formulation CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Formulation CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Formulation CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Formulation CDMO Services Players in 2022
Table 12. World Formulation CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Formulation CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Formulation CDMO Services Player
Table 15. Formulation CDMO Services Market: Company Product Type Footprint
Table 16. Formulation CDMO Services Market: Company Product Application Footprint
Table 17. Formulation CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Formulation CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Formulation CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Formulation CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Formulation CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Formulation CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Formulation CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Formulation CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Formulation CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Formulation CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Formulation CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Formulation CDMO Services Revenue Market Share (2018-2023)
Table 29. World Formulation CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Formulation CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Formulation CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Formulation CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Formulation CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Formulation CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Medicilon Basic Information, Area Served and Competitors
Table 36. Medicilon Major Business
Table 37. Medicilon Formulation CDMO Services Product and Services
Table 38. Medicilon Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medicilon Recent Developments/Updates
Table 40. Medicilon Competitive Strengths & Weaknesses
Table 41. Gliead Basic Information, Area Served and Competitors
Table 42. Gliead Major Business
Table 43. Gliead Formulation CDMO Services Product and Services
Table 44. Gliead Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gliead Recent Developments/Updates
Table 46. Gliead Competitive Strengths & Weaknesses
Table 47. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 48. Boehringer Ingelheim Major Business
Table 49. Boehringer Ingelheim Formulation CDMO Services Product and Services
Table 50. Boehringer Ingelheim Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Boehringer Ingelheim Recent Developments/Updates
Table 52. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 53. Vertex Basic Information, Area Served and Competitors
Table 54. Vertex Major Business
Table 55. Vertex Formulation CDMO Services Product and Services
Table 56. Vertex Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Vertex Recent Developments/Updates
Table 58. Vertex Competitive Strengths & Weaknesses
Table 59. Mirati Therapeutics Basic Information, Area Served and Competitors
Table 60. Mirati Therapeutics Major Business
Table 61. Mirati Therapeutics Formulation CDMO Services Product and Services
Table 62. Mirati Therapeutics Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Mirati Therapeutics Recent Developments/Updates
Table 64. Mirati Therapeutics Competitive Strengths & Weaknesses
Table 65. AMPAC Basic Information, Area Served and Competitors
Table 66. AMPAC Major Business
Table 67. AMPAC Formulation CDMO Services Product and Services
Table 68. AMPAC Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. AMPAC Recent Developments/Updates
Table 70. AMPAC Competitive Strengths & Weaknesses
Table 71. Pfizer Basic Information, Area Served and Competitors
Table 72. Pfizer Major Business
Table 73. Pfizer Formulation CDMO Services Product and Services
Table 74. Pfizer Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pfizer Recent Developments/Updates
Table 76. Pfizer Competitive Strengths & Weaknesses
Table 77. Polypeptide Basic Information, Area Served and Competitors
Table 78. Polypeptide Major Business
Table 79. Polypeptide Formulation CDMO Services Product and Services
Table 80. Polypeptide Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Polypeptide Recent Developments/Updates
Table 82. Polypeptide Competitive Strengths & Weaknesses
Table 83. Bachem Basic Information, Area Served and Competitors
Table 84. Bachem Major Business
Table 85. Bachem Formulation CDMO Services Product and Services
Table 86. Bachem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bachem Recent Developments/Updates
Table 88. Bachem Competitive Strengths & Weaknesses
Table 89. Merck Basic Information, Area Served and Competitors
Table 90. Merck Major Business
Table 91. Merck Formulation CDMO Services Product and Services
Table 92. Merck Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Merck Recent Developments/Updates
Table 94. Merck Competitive Strengths & Weaknesses
Table 95. Asymchem Basic Information, Area Served and Competitors
Table 96. Asymchem Major Business
Table 97. Asymchem Formulation CDMO Services Product and Services
Table 98. Asymchem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Asymchem Recent Developments/Updates
Table 100. Asymchem Competitive Strengths & Weaknesses
Table 101. Zhejiang Jiuzhou Pharmaceutical Basic Information, Area Served and Competitors
Table 102. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 103. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Product and Services
Table 104. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 106. Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Sinopep Basic Information, Area Served and Competitors
Table 108. Sinopep Major Business
Table 109. Sinopep Formulation CDMO Services Product and Services
Table 110. Sinopep Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Sinopep Recent Developments/Updates
Table 112. Sinopep Competitive Strengths & Weaknesses
Table 113. Frontier Biotechnologies Basic Information, Area Served and Competitors
Table 114. Frontier Biotechnologies Major Business
Table 115. Frontier Biotechnologies Formulation CDMO Services Product and Services
Table 116. Frontier Biotechnologies Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Frontier Biotechnologies Recent Developments/Updates
Table 118. Frontier Biotechnologies Competitive Strengths & Weaknesses
Table 119. JYMed Basic Information, Area Served and Competitors
Table 120. JYMed Major Business
Table 121. JYMed Formulation CDMO Services Product and Services
Table 122. JYMed Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. JYMed Recent Developments/Updates
Table 124. JYMed Competitive Strengths & Weaknesses
Table 125. Chengdu Shengnuo Biotechnology Basic Information, Area Served and Competitors
Table 126. Chengdu Shengnuo Biotechnology Major Business
Table 127. Chengdu Shengnuo Biotechnology Formulation CDMO Services Product and Services
Table 128. Chengdu Shengnuo Biotechnology Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Chengdu Shengnuo Biotechnology Recent Developments/Updates
Table 130. Chengdu Shengnuo Biotechnology Competitive Strengths & Weaknesses
Table 131. Shanghai Soho-Yiming Pharmaceuticals Basic Information, Area Served and Competitors
Table 132. Shanghai Soho-Yiming Pharmaceuticals Major Business
Table 133. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Product and Services
Table 134. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
Table 136. Shanghai Soho-Yiming Pharmaceuticals Competitive Strengths & Weaknesses
Table 137. Chinese Peptide Company Basic Information, Area Served and Competitors
Table 138. Chinese Peptide Company Major Business
Table 139. Chinese Peptide Company Formulation CDMO Services Product and Services
Table 140. Chinese Peptide Company Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Chinese Peptide Company Recent Developments/Updates
Table 142. Chinese Peptide Company Competitive Strengths & Weaknesses
Table 143. Ambio Pharmaceuticals Basic Information, Area Served and Competitors
Table 144. Ambio Pharmaceuticals Major Business
Table 145. Ambio Pharmaceuticals Formulation CDMO Services Product and Services
Table 146. Ambio Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Ambio Pharmaceuticals Recent Developments/Updates
Table 148. Ambio Pharmaceuticals Competitive Strengths & Weaknesses
Table 149. Zhejiang Peptites Biotech Basic Information, Area Served and Competitors
Table 150. Zhejiang Peptites Biotech Major Business
Table 151. Zhejiang Peptites Biotech Formulation CDMO Services Product and Services
Table 152. Zhejiang Peptites Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Zhejiang Peptites Biotech Recent Developments/Updates
Table 154. Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
Table 155. STA Pharmaceutical Basic Information, Area Served and Competitors
Table 156. STA Pharmaceutical Major Business
Table 157. STA Pharmaceutical Formulation CDMO Services Product and Services
Table 158. STA Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. STA Pharmaceutical Recent Developments/Updates
Table 160. STA Pharmaceutical Competitive Strengths & Weaknesses
Table 161. Zhejiang Langhua Pharmaceutical Basic Information, Area Served and Competitors
Table 162. Zhejiang Langhua Pharmaceutical Major Business
Table 163. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Product and Services
Table 164. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Zhejiang Langhua Pharmaceutical Recent Developments/Updates
Table 166. Viva Biotech Basic Information, Area Served and Competitors
Table 167. Viva Biotech Major Business
Table 168. Viva Biotech Formulation CDMO Services Product and Services
Table 169. Viva Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 170. Global Key Players of Formulation CDMO Services Upstream (Raw Materials)
Table 171. Formulation CDMO Services Typical Customers
List of Figure
Figure 1. Formulation CDMO Services Picture
Figure 2. World Formulation CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Formulation CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Formulation CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Formulation CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Formulation CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Formulation CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Formulation CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Formulation CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Formulation CDMO Services Markets in 2022
Figure 27. United States VS China: Formulation CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Formulation CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Formulation CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Formulation CDMO Services Market Size Market Share by Type in 2022
Figure 31. Small Molecule CDMO
Figure 32. Macro-molecular CDMO
Figure 33. World Formulation CDMO Services Market Size Market Share by Type (2018-2029)
Figure 34. World Formulation CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Formulation CDMO Services Market Size Market Share by Application in 2022
Figure 36. Clinical Application
Figure 37. Commercial Production
Figure 38. Formulation CDMO Services Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Table 1. World Formulation CDMO Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Formulation CDMO Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Formulation CDMO Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Formulation CDMO Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Formulation CDMO Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Formulation CDMO Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Formulation CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Formulation CDMO Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Formulation CDMO Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Formulation CDMO Services Players in 2022
Table 12. World Formulation CDMO Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Formulation CDMO Services Company Evaluation Quadrant
Table 14. Head Office of Key Formulation CDMO Services Player
Table 15. Formulation CDMO Services Market: Company Product Type Footprint
Table 16. Formulation CDMO Services Market: Company Product Application Footprint
Table 17. Formulation CDMO Services Mergers & Acquisitions Activity
Table 18. United States VS China Formulation CDMO Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Formulation CDMO Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Formulation CDMO Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Formulation CDMO Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Formulation CDMO Services Revenue Market Share (2018-2023)
Table 23. China Based Formulation CDMO Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Formulation CDMO Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Formulation CDMO Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Formulation CDMO Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Formulation CDMO Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Formulation CDMO Services Revenue Market Share (2018-2023)
Table 29. World Formulation CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Formulation CDMO Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Formulation CDMO Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Formulation CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Formulation CDMO Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Formulation CDMO Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Medicilon Basic Information, Area Served and Competitors
Table 36. Medicilon Major Business
Table 37. Medicilon Formulation CDMO Services Product and Services
Table 38. Medicilon Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medicilon Recent Developments/Updates
Table 40. Medicilon Competitive Strengths & Weaknesses
Table 41. Gliead Basic Information, Area Served and Competitors
Table 42. Gliead Major Business
Table 43. Gliead Formulation CDMO Services Product and Services
Table 44. Gliead Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gliead Recent Developments/Updates
Table 46. Gliead Competitive Strengths & Weaknesses
Table 47. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 48. Boehringer Ingelheim Major Business
Table 49. Boehringer Ingelheim Formulation CDMO Services Product and Services
Table 50. Boehringer Ingelheim Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Boehringer Ingelheim Recent Developments/Updates
Table 52. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 53. Vertex Basic Information, Area Served and Competitors
Table 54. Vertex Major Business
Table 55. Vertex Formulation CDMO Services Product and Services
Table 56. Vertex Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Vertex Recent Developments/Updates
Table 58. Vertex Competitive Strengths & Weaknesses
Table 59. Mirati Therapeutics Basic Information, Area Served and Competitors
Table 60. Mirati Therapeutics Major Business
Table 61. Mirati Therapeutics Formulation CDMO Services Product and Services
Table 62. Mirati Therapeutics Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Mirati Therapeutics Recent Developments/Updates
Table 64. Mirati Therapeutics Competitive Strengths & Weaknesses
Table 65. AMPAC Basic Information, Area Served and Competitors
Table 66. AMPAC Major Business
Table 67. AMPAC Formulation CDMO Services Product and Services
Table 68. AMPAC Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. AMPAC Recent Developments/Updates
Table 70. AMPAC Competitive Strengths & Weaknesses
Table 71. Pfizer Basic Information, Area Served and Competitors
Table 72. Pfizer Major Business
Table 73. Pfizer Formulation CDMO Services Product and Services
Table 74. Pfizer Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pfizer Recent Developments/Updates
Table 76. Pfizer Competitive Strengths & Weaknesses
Table 77. Polypeptide Basic Information, Area Served and Competitors
Table 78. Polypeptide Major Business
Table 79. Polypeptide Formulation CDMO Services Product and Services
Table 80. Polypeptide Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Polypeptide Recent Developments/Updates
Table 82. Polypeptide Competitive Strengths & Weaknesses
Table 83. Bachem Basic Information, Area Served and Competitors
Table 84. Bachem Major Business
Table 85. Bachem Formulation CDMO Services Product and Services
Table 86. Bachem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bachem Recent Developments/Updates
Table 88. Bachem Competitive Strengths & Weaknesses
Table 89. Merck Basic Information, Area Served and Competitors
Table 90. Merck Major Business
Table 91. Merck Formulation CDMO Services Product and Services
Table 92. Merck Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Merck Recent Developments/Updates
Table 94. Merck Competitive Strengths & Weaknesses
Table 95. Asymchem Basic Information, Area Served and Competitors
Table 96. Asymchem Major Business
Table 97. Asymchem Formulation CDMO Services Product and Services
Table 98. Asymchem Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Asymchem Recent Developments/Updates
Table 100. Asymchem Competitive Strengths & Weaknesses
Table 101. Zhejiang Jiuzhou Pharmaceutical Basic Information, Area Served and Competitors
Table 102. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 103. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Product and Services
Table 104. Zhejiang Jiuzhou Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 106. Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Sinopep Basic Information, Area Served and Competitors
Table 108. Sinopep Major Business
Table 109. Sinopep Formulation CDMO Services Product and Services
Table 110. Sinopep Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Sinopep Recent Developments/Updates
Table 112. Sinopep Competitive Strengths & Weaknesses
Table 113. Frontier Biotechnologies Basic Information, Area Served and Competitors
Table 114. Frontier Biotechnologies Major Business
Table 115. Frontier Biotechnologies Formulation CDMO Services Product and Services
Table 116. Frontier Biotechnologies Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Frontier Biotechnologies Recent Developments/Updates
Table 118. Frontier Biotechnologies Competitive Strengths & Weaknesses
Table 119. JYMed Basic Information, Area Served and Competitors
Table 120. JYMed Major Business
Table 121. JYMed Formulation CDMO Services Product and Services
Table 122. JYMed Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. JYMed Recent Developments/Updates
Table 124. JYMed Competitive Strengths & Weaknesses
Table 125. Chengdu Shengnuo Biotechnology Basic Information, Area Served and Competitors
Table 126. Chengdu Shengnuo Biotechnology Major Business
Table 127. Chengdu Shengnuo Biotechnology Formulation CDMO Services Product and Services
Table 128. Chengdu Shengnuo Biotechnology Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Chengdu Shengnuo Biotechnology Recent Developments/Updates
Table 130. Chengdu Shengnuo Biotechnology Competitive Strengths & Weaknesses
Table 131. Shanghai Soho-Yiming Pharmaceuticals Basic Information, Area Served and Competitors
Table 132. Shanghai Soho-Yiming Pharmaceuticals Major Business
Table 133. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Product and Services
Table 134. Shanghai Soho-Yiming Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
Table 136. Shanghai Soho-Yiming Pharmaceuticals Competitive Strengths & Weaknesses
Table 137. Chinese Peptide Company Basic Information, Area Served and Competitors
Table 138. Chinese Peptide Company Major Business
Table 139. Chinese Peptide Company Formulation CDMO Services Product and Services
Table 140. Chinese Peptide Company Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Chinese Peptide Company Recent Developments/Updates
Table 142. Chinese Peptide Company Competitive Strengths & Weaknesses
Table 143. Ambio Pharmaceuticals Basic Information, Area Served and Competitors
Table 144. Ambio Pharmaceuticals Major Business
Table 145. Ambio Pharmaceuticals Formulation CDMO Services Product and Services
Table 146. Ambio Pharmaceuticals Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Ambio Pharmaceuticals Recent Developments/Updates
Table 148. Ambio Pharmaceuticals Competitive Strengths & Weaknesses
Table 149. Zhejiang Peptites Biotech Basic Information, Area Served and Competitors
Table 150. Zhejiang Peptites Biotech Major Business
Table 151. Zhejiang Peptites Biotech Formulation CDMO Services Product and Services
Table 152. Zhejiang Peptites Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Zhejiang Peptites Biotech Recent Developments/Updates
Table 154. Zhejiang Peptites Biotech Competitive Strengths & Weaknesses
Table 155. STA Pharmaceutical Basic Information, Area Served and Competitors
Table 156. STA Pharmaceutical Major Business
Table 157. STA Pharmaceutical Formulation CDMO Services Product and Services
Table 158. STA Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. STA Pharmaceutical Recent Developments/Updates
Table 160. STA Pharmaceutical Competitive Strengths & Weaknesses
Table 161. Zhejiang Langhua Pharmaceutical Basic Information, Area Served and Competitors
Table 162. Zhejiang Langhua Pharmaceutical Major Business
Table 163. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Product and Services
Table 164. Zhejiang Langhua Pharmaceutical Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Zhejiang Langhua Pharmaceutical Recent Developments/Updates
Table 166. Viva Biotech Basic Information, Area Served and Competitors
Table 167. Viva Biotech Major Business
Table 168. Viva Biotech Formulation CDMO Services Product and Services
Table 169. Viva Biotech Formulation CDMO Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 170. Global Key Players of Formulation CDMO Services Upstream (Raw Materials)
Table 171. Formulation CDMO Services Typical Customers
List of Figure
Figure 1. Formulation CDMO Services Picture
Figure 2. World Formulation CDMO Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Formulation CDMO Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Formulation CDMO Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Formulation CDMO Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Formulation CDMO Services Revenue (2018-2029) & (USD Million)
Figure 13. Formulation CDMO Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Formulation CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Formulation CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Formulation CDMO Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Formulation CDMO Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Formulation CDMO Services Markets in 2022
Figure 27. United States VS China: Formulation CDMO Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Formulation CDMO Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Formulation CDMO Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Formulation CDMO Services Market Size Market Share by Type in 2022
Figure 31. Small Molecule CDMO
Figure 32. Macro-molecular CDMO
Figure 33. World Formulation CDMO Services Market Size Market Share by Type (2018-2029)
Figure 34. World Formulation CDMO Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Formulation CDMO Services Market Size Market Share by Application in 2022
Figure 36. Clinical Application
Figure 37. Commercial Production
Figure 38. Formulation CDMO Services Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
